KEGG pathways enriched in the high-risk group included KEGG P53 signaling pathway, KEGG cell cycle, KEGG base excision repair, KEGG pancreatic cancer, and KEGG mismatch repair. This evidence concerns the gene TP53 and familial pancreatic carcinoma.